These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3105826)

  • 21. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes.
    Unemo M; Fasth O; Fredlund H; Limnios A; Tapsall J
    J Antimicrob Chemother; 2009 Jun; 63(6):1142-51. PubMed ID: 19318360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hierarchical self-organization in the finitary process soup.
    Görnerup O; Crutchfield JP
    Artif Life; 2008; 14(3):245-54. PubMed ID: 18489247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA; Mauldin PD; Steed LL
    Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reevaluation of antibiotic breakpoints.
    Phillips I
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S230-2. PubMed ID: 11519009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretation and use of statistics in nursing research.
    Giuliano KK; Polanowicz M
    AACN Adv Crit Care; 2008; 19(2):211-22. PubMed ID: 18560290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.
    Jorgensen JH; Ferraro MJ
    Clin Infect Dis; 2000 May; 30(5):799-808. PubMed ID: 10816150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal use of antibiotic resistance surveillance systems.
    Critchley IA; Karlowsky JA
    Clin Microbiol Infect; 2004 Jun; 10(6):502-11. PubMed ID: 15191377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(7):152-4. PubMed ID: 14985653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular identification of mycobacteria and detection of antibiotic resistance].
    Cattoir V
    Ann Biol Clin (Paris); 2004; 62(4):405-13. PubMed ID: 15297234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Foundations of the new phylogenetics].
    Pavlinov IIa
    Zh Obshch Biol; 2004; 65(4):334-66. PubMed ID: 15490579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technology assessment in critical care: understanding statistical analyses used to assess agreement between methods of clinical measurement.
    Szaflarski NL; Slaughter RE
    Am J Crit Care; 1996 May; 5(3):207-16. PubMed ID: 8722924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Better control of antibiotic resistance.
    Guillemot D; Courvalin P;
    Clin Infect Dis; 2001 Aug; 33(4):542-7. PubMed ID: 11462192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment.
    Clark LH; Setzer RW; Barton HA
    Risk Anal; 2004 Dec; 24(6):1697-717. PubMed ID: 15660623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parameterization and evaluation of a spatiotemporal model of the potato late blight pathosystem.
    Skelsey P; Kessel GJ; Rossing WA; van der Werf W
    Phytopathology; 2009 Mar; 99(3):290-300. PubMed ID: 19203282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Definition of normal values in medicine].
    Agnese G
    Arch Sci Med (Torino); 1975; 132(4):139-50. PubMed ID: 1230134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Computer management of antibiogram data (author's transl)].
    Schito GC
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():586-610. PubMed ID: 555530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Statistical evaluation of an official analytical method. Microbiological assay with the "point against a standard curve" method].
    Neri G; Racchelli L; Recusani F
    Farmaco Prat; 1974 Apr; 29(4):205-12. PubMed ID: 4827881
    [No Abstract]   [Full Text] [Related]  

  • 40. Multidimensional analysis for interpreting antibiotic susceptibility data.
    Scavizzi MR; Elbhar A; Fénelon JP; Bronner FD
    Antimicrob Agents Chemother; 1993 Apr; 37(4):929. PubMed ID: 8494397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.